Showing 2,581 - 2,600 results of 8,597 for search 'effective dysfunction', query time: 0.15s Refine Results
  1. 2581
  2. 2582
  3. 2583

    Chain length-dependent mitochondrial toxicity of perfluoroalkyl carboxylic acids: insights from Mito Tox Index evaluation by Yoonseok Kam, Lisa Winer, Natalia Romero

    Published 2025-07-01
    “…The results suggest that PFCA-induced mitochondrial dysfunction is a key mechanism of PFAS-mediated cellular damage, primarily driven by proton leak-mediated ETC uncoupling, leading to impaired mitochondrial energy production. …”
    Get full text
    Article
  4. 2584

    Long-term exposure to air pollution and liver fibrosis in the elderly with MASLD by Yanqi Lan, Haixia Zhang, Ahua Wu, Jiankang Huang, Zhinan Guo, Youlan Chen

    Published 2025-08-01
    “…Abstract This study aimed to investigate the relationship between air pollutants (AP) and liver fibrosis in the older Chinese population with metabolic dysfunction-associated steatotic liver disease (MASLD). …”
    Get full text
    Article
  5. 2585

    Association of the polymorphism in the androgen receptor gene and endothelial function in men with type 2 diabetes by Irina Alekseevna Khripun, Sergey Vladislavovich Vorobyev, Michael Iosifovich Kogan

    Published 2015-12-01
    “…In recent years, actively studied the effect of androgen deficiency on the cardiovascular system, including endothelial function. …”
    Get full text
    Article
  6. 2586
  7. 2587
  8. 2588
  9. 2589

    Impact of polyethylene terephthalate and polylactic acid nanoplastics on cellular uptake and lipid metabolism in differentiated 3T3-L1 adipocytes by Yu-Tung Jhang, Ching-Hao Li, Chih-En Yeh, Yen-Ju Chan, Tsung-Min Yang, Carlos Jose Quiroz Reyes, Ching-Wei Lin, I-Lun Hsiao

    Published 2025-09-01
    “…This study first proved that NPl-induced lipolysis of adipocytes is dependent on the plastic type, which serves as a basis for future concerns about NPl effects on cardiovascular disease and non-alcoholic fatty liver disease driven by adipocyte dysfunction.…”
    Get full text
    Article
  10. 2590

    GrpEL1 overexpression mitigates hippocampal neuron damage via mitochondrial unfolded protein response after experimental status epilepticus by Minjia Xie, Xin Wu, Xi Liu, Longyuan Li, Feng Gu, Xinyu Tao, Bingyi Song, Lei Bai, Di Li, Haitao Shen, Zongqi Wang, Wei Gao

    Published 2025-03-01
    “…Methods: The effects of GrpEL1 were assessed in vivo using a Lithium-pilocarpine rat model of SE and in vitro with glutamate-treated HT22 hippocampal cells. …”
    Get full text
    Article
  11. 2591

    New AIE Emitters from the Unexpected Boron Tribromide/Boron Trichloride‐mediated Cyclization Reaction and Application for Fluorescence Imaging of Lipid Droplets by Yichen Hu, Xin Gao, Junlong Ma, Zhichun Shangguan, Liangliang Chen, Guanxin Zhang, Xi‐Sha Zhang, Cheng Li, Yanbang Li, Deqing Zhang

    Published 2025-04-01
    “…ABSTRACT The aberrant behavior of lipid droplets (LDs) is often indicative of cellular dysfunction, which may contribute to the development of a range of diseases, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD) and atherosclerosis (AS). …”
    Get full text
    Article
  12. 2592
  13. 2593
  14. 2594

    Elucidating Early Radiation-Induced Cardiotoxicity Markers in Preclinical Genetic Models Through Advanced Machine Learning and Cardiac MRI by Dayeong An, El-Sayed Ibrahim

    Published 2024-12-01
    “…These findings suggest that ML, combined with cardiac MRI, can effectively detect early preclinical changes in RIHD, particularly alterations in regional myocardial contractility, highlighting the potential of these techniques for early detection and monitoring of radiation-induced cardiac dysfunction.…”
    Get full text
    Article
  15. 2595

    Bidirectional Association between Thyroid Function and Glycemic Status: A Cross-Sectional Study by Zeynep Kusku Kiraz, Evin Kocatürk, Ezgi Kar

    Published 2025-08-01
    “…Aim: Diabetes and thyroid dysfunctions have similar mechanisms, and they may be overlooked or undiagnosed. …”
    Get full text
    Article
  16. 2596

    Features of correction of metabolic disorders in women with polycystic ovary syndrome by O.V. Bulavenko, D.G. Konkov, O.A. Taran, O.V. Furman, V.V. Klivak

    Published 2024-10-01
    “…Most symptoms of PCOS are associated with insulin resistance, type II diabetes, decreased levels of sex hormone-binding globulin, increased levels of alanine aminotransferase and aspartate aminotransferase, which may indicate liver dysfunction. The metabolic profile and function of the ovaries can be affected by any pathological changes in the levels of systemic metabolism and/or in peripheral organs, in particular the liver, which serves as the metabolic center of the body, mediating its effects through the liver-ovary axis. …”
    Get full text
    Article
  17. 2597
  18. 2598
  19. 2599

    Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention by Bassim El‐Sabawi, Kahraman Tanriverdi, Priya Gajjar, Matthew Nayor, Joshua M. Landman, Jennifer E. Below, Madeleine Haff, Michelle Long, Mark Ezpeleta, Jane E. Freedman, Krista Varady, Ravi Shah, Andrew S. Perry

    Published 2025-05-01
    “…Background Weight reduction through lifestyle, activity, and dietary interventions are the mainstay of initial therapy for metabolic dysfunction associated steatotic liver disease. Data on the relative effectiveness and metabolic pathways linking weight loss and decreased hepatic steatosis are lacking. …”
    Get full text
    Article
  20. 2600